A large‐scale multicenter study validates aldo‐keto reductase family 1 member B10 as a prevalent serum marker for detection of hepatocellular carcinoma X Ye, C Li, X Zu, M Lin, Q Liu, J Liu, G Xu, Z Chen, Y Xu, L Liu, D Luo, ... Hepatology 69 (6), 2489-2501, 2019 | 69 | 2019 |
Exosomal neutral sphingomyelinase 1 suppresses hepatocellular carcinoma via decreasing the ratio of sphingomyelin/ceramide M Lin, W Liao, M Dong, R Zhu, J Xiao, T Sun, Z Chen, B Wu, J Jin The FEBS Journal 285 (20), 3835-3848, 2018 | 44 | 2018 |
p53-inducible long non-coding RNA PICART1 mediates cancer cell proliferation and migration Y Cao, M Lin, Y Bu, H Ling, Y He, C Huang, Y Shen, B Song, D Cao International journal of oncology 50 (5), 1671-1682, 2017 | 35 | 2017 |
Characterization of genomic alterations in Chinese colorectal cancer patients W Huang, H Li, X Shi, M Lin, C Liao, S Zhang, W Shi, L Zhang, X Zhang, ... Japanese Journal of Clinical Oncology 51 (1), 120-129, 2021 | 13 | 2021 |
Correlation of KMT2 family mutations with molecular characteristics and prognosis in colorectal cancer C Liao, W Huang, M Lin, H Li, Z Zhang, X Zhang, R Chen, M Huang, P Yu, ... The International Journal of Biological Markers 37 (2), 149-157, 2022 | 10 | 2022 |
Impaired barrier function and immunity in the colon of aldo-keto reductase 1B8 deficient mice X Wang, R Khoshaba, Y Shen, Y Cao, M Lin, Y Zhu, Z Cao, DF Liao, ... Frontiers in Cell and Developmental Biology 9, 632805, 2021 | 9 | 2021 |
Rhodium (II) complex with 2-benzoylpyridine, a novel potential chemotherapeutic drug, induces cell cycle arrest and apoptosis in HepG2 cells X Wang, Y Li, M Lin, J Jin, Z Huang Biometals 30, 903-915, 2017 | 8 | 2017 |
A Large-Scale Multicenter Study Validates AKR1B10 as a New Prevalent Serum Marker for Detection of Hepatocellular Carcinoma. X Ye, C Li, X Zu, M Lin, Q Liu, J Liu, G Xu, Z Chen, Y Xu, L Liu, D Luo, ... | 7 | 2019 |
Cancer, obesity, and diabetes: TKIs exert multiple effects on glucose homeostasis M Lin, J Jin Nature Reviews Clinical Oncology 14 (5), 268-268, 2017 | 4 | 2017 |
Sphingolipid metabolism affects the anticancer effect of cisplatin YL Li, ML Lin, SQ He, JF Jin World Journal of Translational Medicine 5 (1), 37-45, 2016 | 3 | 2016 |
Down-regulation of neutral sphingomyelinase 1 to predict prognosis in hepatocellular carcinoma. M Lin, W Liao, J Jin Journal of Clinical Oncology 35 (15_suppl), e15647-e15647, 2017 | | 2017 |